1. The genetic basis of classic nonketotic hyperglycinemia due to mutations in GLDC and AMT;Coughlin;Anesthesia Analg.,2017
2. Valle, D.L., Antonarakis, S., Ballabio, A., Beaudet, A.L., and Mitchell, G.A. (2019). The Online Metabolic and Molecular Bases of Inherited Disease, McGraw Hill.
3. van Hove, J.L.K., Coughlin, C., Swanson, M., Hennermann, J.B., Adam, M.P., Everman, D.B., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Bean, L.J.H. (1993). GeneReviews® [Internet], University of Washington.
4. Recurrent Mutations in P- and T-Proteins of the Glycine Cleavage Complex and a Novel T-Protein Mutation (N145I): A Strategy for the Molecular Investigation of Patients with Nonketotic Hyperglycinemia (NKH);Toone;Mol. Genet. Metab.,2001
5. Nowak, M., Chuchra, P., and Paprocka, J. (2022). Nonketotic Hyperglycinemia: Insight into Current Therapies. J. Clin. Med., 11.